chronic obstructive pulmonary disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Consistent with COPD and stable; 2. Those who meet the classification criteria of TCM syndrome differentiation of phlegm-stasis obstructive lung syndrome; 3. Aged 40-80 years; 4. Did not participate in other clinical studies 3 months before enrollment; 5. Voluntarily receive treatment and sign informed consent; 6. No antibiotics were used 3 months before enrollment.
Exclusion criteria
Exclusion criteria: 1. Patients who are allergic to the test drug or known components of the control drug; 2. Patients with extremely severe COPD and patients with acute exacerbation; 3. Pregnant and lactating patients; 4. Delirious, dementia, various mental patients; 5. Patients with cardiac function grade ? and hemodynamic instability; 6. Neuromuscular diseases affecting respiratory and motor function, such as bronchiectasis, bronchial asthma, active pulmonary tuberculosis, pulmonary embolism, pneumothorax, pleural effusion, and malignant tumor; 7. Severe liver and kidney diseases (severe liver diseases refer to bleeding from cirrhosis, portal hypertension and varicose veins, and severe kidney diseases including dialysis and kidney transplantation); 8. Those in bed for a long time for various reasons; 9. Patients who have participated in other interventional clinical trials within the last 3 months; 10. The investigator considered it inappropriate to participate in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lung function;Number of acute exacerbations;Number of colds; | — |
Secondary
| Measure | Time frame |
|---|---|
| Chronic Obstructive Pulmonary Disease Score (CAT);Dyspnea grading;COPD-PRO Scale;Short Form Health Survey (SF-36);Self-rating Depression Scale;Self-rating Anxiety Scale;6-minute walking distance; | — |
Countries
China
Contacts
Anhui University of Chinese Medicine